208 related articles for article (PubMed ID: 25613565)
41. The Challenge of a "Functional Cure" for AIDS by Gene Modified HSCT Therapy.
Xu L; Chen H; Zhang B
Curr Stem Cell Res Ther; 2015; 10(6):492-8. PubMed ID: 25986619
[TBL] [Abstract][Full Text] [Related]
42. Genetic modification of hematopoietic stem cells as a therapy for HIV/AIDS.
Younan P; Kowalski J; Kiem HP
Viruses; 2013 Nov; 5(12):2946-62. PubMed ID: 24287598
[TBL] [Abstract][Full Text] [Related]
43. Distribution of three HIV-1 resistance-conferring polymorphisms (SDF1-3'A, CCR2-641, and CCR5-delta32) in global populations.
Su B; Sun G; Lu D; Xiao J; Hu F; Chakraborty R; Deka R; Jin L
Eur J Hum Genet; 2000 Dec; 8(12):975-9. PubMed ID: 11175286
[TBL] [Abstract][Full Text] [Related]
44. Knowledge From London and Berlin: Finding Threads to a Functional HIV Cure.
Ding J; Liu Y; Lai Y
Front Immunol; 2021; 12():688747. PubMed ID: 34122453
[TBL] [Abstract][Full Text] [Related]
45. Hematopoietic cell transplantation with cord blood for cure of HIV infections.
Petz LD; Redei I; Bryson Y; Regan D; Kurtzberg J; Shpall E; Gutman J; Querol S; Clark P; Tonai R; Santos S; Bravo A; Spellman S; Gragert L; Rossi J; Li S; Li H; Senitzer D; Zaia J; Rosenthal J; Forman S; Chow R
Biol Blood Marrow Transplant; 2013 Mar; 19(3):393-7. PubMed ID: 23089564
[TBL] [Abstract][Full Text] [Related]
46. Stromal cell-derived factor (SDF) 1-3'A polymorphism may play a role in resistance to HIV-1 infection in seronegative high-risk Thais.
Tiensiwakul P
Intervirology; 2004; 47(2):87-92. PubMed ID: 15192272
[TBL] [Abstract][Full Text] [Related]
47. Impact of highly active antiretroviral treatment on expression of HIV-1 coreceptors and ligand levels in peripheral blood from HIV-1 infected patients in China.
Fang J; Bai S; Wu L; Zhu X; Yao X; Jin C; Wang C
J Int Med Res; 2013 Oct; 41(5):1560-9. PubMed ID: 24043708
[TBL] [Abstract][Full Text] [Related]
48. Transplantation in HIV-infected subjects: is cure possible?
Zaia JA; Forman SJ
Hematology Am Soc Hematol Educ Program; 2013; 2013():389-93. PubMed ID: 24319209
[TBL] [Abstract][Full Text] [Related]
49. HIV cure: Are we going to make history?
Payra S; Manjhi PK; Singh S; Kumar R; Singh SK; Kumar A; Maharshi V
HIV Med; 2024 Mar; 25(3):322-331. PubMed ID: 37821095
[TBL] [Abstract][Full Text] [Related]
50. Killing two birds with one stone: CRISPR/Cas9 CCR5 knockout hematopoietic stem cells transplantation to treat patients with HIV infection and hematological malignancies concurrently.
Au TY; Arudkumar J; Assavarittirong C; Benjamin S
Clin Exp Med; 2023 Dec; 23(8):4163-4175. PubMed ID: 37500934
[TBL] [Abstract][Full Text] [Related]
51. HIV/AIDS: modified stem cells in the spotlight.
Armijo E; Soto C; Davis BR
Cell Mol Life Sci; 2014 Jul; 71(14):2641-9. PubMed ID: 24509823
[TBL] [Abstract][Full Text] [Related]
52. Stem cell directed gene therapy.
Engel BC; Kohn DB
Front Biosci; 1999 May; 4():e26-33. PubMed ID: 10228093
[TBL] [Abstract][Full Text] [Related]
53. Thresholds for post-rebound SHIV control after CCR5 gene-edited autologous hematopoietic cell transplantation.
Cardozo-Ojeda EF; Duke ER; Peterson CW; Reeves DB; Mayer BT; Kiem HP; Schiffer JT
Elife; 2021 Jan; 10():. PubMed ID: 33432929
[TBL] [Abstract][Full Text] [Related]
54. CCR5-edited gene therapies for HIV cure: Closing the door to viral entry.
Haworth KG; Peterson CW; Kiem HP
Cytotherapy; 2017 Nov; 19(11):1325-1338. PubMed ID: 28751153
[TBL] [Abstract][Full Text] [Related]
55. Stem cell-based therapies for HIV/AIDS.
Pernet O; Yadav SS; An DS
Adv Drug Deliv Rev; 2016 Aug; 103():187-201. PubMed ID: 27151309
[TBL] [Abstract][Full Text] [Related]
56. Engineering hematopoietic stem cells toward a functional cure of human immunodeficiency virus infection.
Wang J; Holmes MC
Cytotherapy; 2016 Nov; 18(11):1370-1381. PubMed ID: 27745602
[TBL] [Abstract][Full Text] [Related]
57. Inducing CCR5Δ32/Δ32 Homozygotes in the Human Jurkat CD4+ Cell Line and Primary CD4+ Cells by CRISPR-Cas9 Genome-Editing Technology.
Qi C; Li D; Jiang X; Jia X; Lu L; Wang Y; Sun J; Shao Y; Wei M
Mol Ther Nucleic Acids; 2018 Sep; 12():267-274. PubMed ID: 30195765
[TBL] [Abstract][Full Text] [Related]
58. Preventing HIV transmission through blockade of CCR5: rationale, progress and perspectives.
Hartley O; Martins E; Scurci I
Swiss Med Wkly; 2018; 148():w14580. PubMed ID: 29376550
[TBL] [Abstract][Full Text] [Related]
59. The use of cell-delivered gene therapy for the treatment of HIV/AIDS.
Symonds GP; Johnstone HA; Millington ML; Boyd MP; Burke BP; Breton LR
Immunol Res; 2010 Dec; 48(1-3):84-98. PubMed ID: 20737298
[TBL] [Abstract][Full Text] [Related]
60. Gene Therapy to Cure HIV: Where to from Here?
Johnston R
AIDS Patient Care STDS; 2016 Dec; 30(12):531-533. PubMed ID: 27905839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
